CoveBridge Inc.

Established CoveBridge Inc. with a capital of 18 million yen by Chairman Joseph Covey and President Akemi Minegishi (Fukumori), specializing in overseas capabilities for pharmaceutical and medical device application procedures. Started operations at the office in Hongo 2-chome, Bunkyo Ward. Became a certified small and medium enterprise under the 'Small and Medium Enterprise Employment Creation Human Resource Securing Subsidy' through improvement plan certification.

Co-Bridge Corporation was established in July 1999.

Joined the Tokyo Chamber of Commerce and Industry.

Increased capital to 21 million yen. Began sponsorship support for Plan Japan.

Relocated headquarters to Hongo 3-chome, Bunkyo Ward.

Started exhibiting at U.S. medical products exhibitions.

Joseph Covey, chairman (current director), gave a lecture at the Stata User Group Meeting in Boston, a meeting of North American statistical analysts.

Joined the Japan Medical Equipment Industry Association.

Started exhibiting at the International Bio Expo.

Joined the Osaka Pharmaceutical Association.

Joseph Covey, chairman (current director), gave a lecture at the Stata User Group Meeting in Boston, a meeting of North American statistical analysts.

Started accepting contracts for the management of designated manufacturing and sales businesses for Class II medical devices and quasi-drugs, and domestic managers of drug master files, following the enforcement of the new Pharmaceutical Affairs Law.

Japan Medical Devices Industry Association Membership

At the Stata User Group Meeting in Boston, a meeting of statisticians from the United States, Chairman (currently Director) Joseph Coveney gave a lecture

Relocated headquarters to Hirakawacho, Chiyoda-ku

Relocated the main office of the designated manufacturing and sales business to Hirakawacho, Chiyoda-ku

Obtained a license for Class I Medical Device Manufacturing and Sales

Obtained a license for manufacturing and sales of in vitro diagnostic medical devices

Became a member of the WDB Group: increased capital to 50 million yen

Relocated headquarters to Marunouchi, Chiyoda-ku

Increased capital to 110 million yen